Dade Behring Grants Sublicense to Beckman Coulter for the Use of Cardiac Markers

Dade Behring Inc., the world’s largest company solely dedicated to clinical diagnostics, announced that it has granted certain rights to Beckman Coulter for the combined use of the emerging cardiac markers placental growth factor (PIGF), soluble fms-like tyrosine kinase 1(sFlt-1), soluble CD40 ligand (sCD40L) and pregnancy associated plasma protein-A (PAPP-A).
Dade Behring